Endovascular Treatment of Congenital Portosystemic Shunt: A Single-Center Prospective Study
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: To design a prospective study on endovascular closure of congenital portosystemic shunts. The primary endpoint was to assess the safety of endovascular closure. The secondary endpoint was to evaluate the clinical, analytical and imaging outcomes of treatment. Methods: Fifteen patients (age range: 2 days to 21 years; 10 male) were referred to our center due to congenital portosystemic shunts. The following data were collected prior to treatment: age, sex, medical history, clinical and analytical data, urine trimethylaminuria, abdominal-US, and body-CT. The following data were collected at the time of intervention: anatomical and hemodynamic characteristics of the shunts, device used, and closure success. The following data were collected at various post-intervention time points: during hospital stay (to confirm shunt closure and detect complications) and at one year after (for clinical, analytical, and imaging purposes). Results: The treatment was successful in 12 participants, migration of the device was observed in two, while acute splanchnic thrombosis was observed in one. Off-label devices were used in attempting to close the side-to-side shunts, and success was achieved using Amplatzer™ Ductus-Occluder and Amplatzer™ Muscular-Vascular-Septal-Defect-Occluder. The main changes were: increased prothrombin activity (p=0.043); decreased AST, ALT, GGT, and bilirubin (p=0.007, p=0.056, p=0.036, p=0.013); thrombocytopenia resolution (p=0.131); expansion of portal veins (p=0.005); normalization of Doppler portal flow (100%); regression of liver nodules (p=0.001); ammonia normalization (p=0.003); and disappearance of trimethylaminuria (p=0.285). Conclusion: Endovascular closure is effective. Our results support the indication of endovascular closure for side-to-side shunts and for cases of congenital absence of portal vein.
Abstract
Purpose: To design a prospective study on endovascular closure of congenital portosystemic shunts. The primary endpoint was to assess the safety of endovascular closure. The secondary endpoint was to evaluate the clinical, analytical and imaging outcomes of treatment. Methods: Fifteen patients (age range: 2 days to 21 years; 10 male) were referred to our center due to congenital portosystemic shunts. The following data were collected prior to treatment: age, sex, medical history, clinical and analytical data, urine trimethylaminuria, abdominal-US, and body-CT. The following data were collected at the time of intervention: anatomical and hemodynamic characteristics of the shunts, device used, and closure success. The following data were collected at various post-intervention time points: during hospital stay (to confirm shunt closure and detect complications) and at one year after (for clinical, analytical, and imaging purposes). Results: The treatment was successful in 12 participants, migration of the device was observed in two, while acute splanchnic thrombosis was observed in one. Off-label devices were used in attempting to close the side-to-side shunts, and success was achieved using Amplatzer™ Ductus-Occluder and Amplatzer™ Muscular-Vascular-Septal-Defect-Occluder. The main changes were: increased prothrombin activity (p=0.043); decreased AST, ALT, GGT, and bilirubin (p=0.007, p=0.056, p=0.036, p=0.013); thrombocytopenia resolution (p=0.131); expansion of portal veins (p=0.005); normalization of Doppler portal flow (100%); regression of liver nodules (p=0.001); ammonia normalization (p=0.003); and disappearance of trimethylaminuria (p=0.285). Conclusion: Endovascular closure is effective. Our results support the indication of endovascular closure for side-to-side shunts and for cases of congenital absence of portal vein.
참고문헌 (34)
- Guérin F, "Congenital portosystemic vascular malformations", Semin Pediatr Surg, 21, pp.233~234 (2012)
- Hao Y, "Congenital absence of the portal vein associated with focal nodular hyperplasia of the liver and congenital heart disease(Abernethy malformation) : a case report and literature review", Oncol Lett, 9, pp.695~700 (2015)
- Turkbey B, "Multiple hyperplastic nodules in the liver with congenital absence of portal vein : MRI findings", Pediatr Radiol, 36, pp.445~448 (2006)
- Pupulim LF, "Congenital portosystemic shunts associated with liver tumours", Clin Radiol, 68, pp.e362~9 (2013)
- Peker A, "Congenital absence of portal vein associated with nodular regenerative hyperplasia of the liver and pulmonary hypertension", Clin Imaging, 33, pp.322~325 (2009)
- Lautz TB, "Hepatoblastoma in children with congenital portosystemic shunts", J Pediatr Gastroenterol Nutr, 62, pp.542~545 (2016)
- Correa C, "Hepatoblastoma and Abernethy malformation type I : case report", J Pediatr Hematol Oncol, 39, pp.e79~81 (2017)
- Barton JW 3rd, "Liver transplantation for hepatoblastoma in a child with congenital absence of the portal vein", Pediatr Radiol, 20, pp.113~114 (1989)
- Kawano S, "Hepatoblastoma with congenital absence of the portal vein-a case report", Eur J Pediatr Surg, 17, pp.292~294 (2007)
- Kanazawa H, "The classification based on intrahepatic portal system for congenital portosystemic shunts", J Pediatr Surg, 50, pp.688~695 (2015)
- Morikawa N, "Resolution of hepatopulmonary syndrome after ligation of a portosystemic shunt in a pediatric patient with an Abernethy malformation", J Pediatr Surg, 43, pp.e35~8 (2008)
- Osorio MJ, "Abernethy malformation complicated by hepatopulmonary syndrome and a liver mass successfully treated by liver transplantation", Pediatr Transplant, 15, pp.E149~51 (2011)
- Fu L, "Congenital extrahepatic portosystemic shunt : an underdiagnosed but treatable cause of hepatopulmonary syndrome", Eur J Pediatr, 175, pp.195~201 (2016)
- Iida T, "Successful treatment of pulmonary hypertension secondary to congenital extrahepatic portocaval shunts(Abernethy type 2)by living donor liver transplantation after surgical shunt ligation", Transpl Int, 23, pp.105~109 (2010)
- Ersch J, "An infant with pulmonary hypertension due to a congenital porto-caval shunt", Eur J Pediatr, 161, pp.660~662 (2002)
- Eroglu Y, "Improved neurocognitive function after radiologic closure of congenital portosystemic shunts", J Pediatr Gastroenterol Nutr, 39, pp.410~417 (2004)
- Bernard O, "Congenital portosystemic shunts in children : recognition, evaluation, and management", Semin Liver Dis, 32, pp.273~287 (2012)
- Ono H, "Clinical features and outcome of eight infants with intrahepatic porto-venous shunts detected in neonatal screening for galactosaemia", Acta Paediatr, 87, pp.631~634 (1998)
- Franchi-Abella S, "Complications of congenital portosystemic shunts in children : therapeutic options and outcomes", J Pediatr Gastroenterol Nutr, 51, pp.322~330 (2010)
- Brasoveanu V, "Living donor liver transplantation for unresectable liver adenomatosis associated with congenital absence of portal vein : a case report and literature review", Am J Case Rep, 16, pp.637~644 (2015)
- Kasahara M, "Living donor liver transplantation for congenital absence of the portal vein with situs inversus", Liver Transpl, 15, pp.1641~1643 (2009)
- Uchida H, "Living donor liver transplantation with renoportal anastomosis for a patient with congenital absence of the portal vein", Case Rep Surg, 2012, pp.670289~ (2012)
- Matsuura T, "Auxiliary partial orthotopic living donor liver transplantation with a small-for-size graft for congenital absence of the portal vein", Liver Transpl, 16, pp.1437~1439 (2010)
- Matsumoto N, "Pediatric living donor liver transplantation for congenital absence of the portal vein with pulmonary hypertension : a case report", Transplant Proc, 52, pp.630~633 (2020)
- Rosenberg HK, "Normal splenic size in infants and children : sonographic measurements", AJR Am J Roentgenol, 157, pp.119~121 (1991)
- Bruckheimer E, "Staged transcatheter treatment of portal hypoplasia and congenital portosystemic shunts in children", Cardiovasc Intervent Radiol, 36, pp.1580~1585 (2013)
- Gülşen Z, "Multiple regenerative nodular hyperplasia in the left infrarenal vena cava accompanied by Abernethy malformation", Surg Radiol Anat, 38, pp.373~378 (2016)
- Chandler TM, "Multiple focal nodular hyperplasia lesions of the liver associated with congenital absence of the portal vein", Magn Reson Imaging, 29, pp.881~886 (2011)
- Yamagami T, "Successful embolization using interlocking detachable coils for a congenital extrahepatic portosystemic venous shunt in a child", J Pediatr Surg, 42, pp.1949~1952 (2007)
- Grimaldi C, "Congenital intrahepatic portohepatic shunt managed by interventional radiologic occlusion : a case report and literature review", J Pediatr Surg, 47, pp.e27~31 (2012)
- Messenger J, "A review of trimethylaminuria : (fish odor syndrome)", J Clin Aesthet Dermatol, 6, pp.45~48 (2013)
- Fernandez MS, "Congenital intrahepatic portocaval shunt associated with trimethylaminuria", Pediatr Surg Int, 12, pp.196~197 (1997)
- Bas S, "Premature pubarche, hyperinsulinemia and hypothyroxinemia : novel manifestations of congenital portosystemic shunts(Abernethy malformation)in children", Horm Res Paediatr, 83, pp.282~287 (2015)
- Satoh M, "Two hyperandrogenic adolescent girls with congenital portosystemic shunt", Eur J Pediatr, 160, pp.307~311 (2001)